Soutien au renforcement des capacités de recherche / Formation Designing Life: The Brave New World of Genome Editing
Le Groupe de recherche en santé et droit de McGill (GRSD), en collaboration avec l’Institut des politique sociales et de la santé, tiendra prochainement un panel intitulé Designing Life: The Brave New World of Genome Editing. L'évènement se déroulera le mardi 16 mars 2016 de 17h30 à 19h00 au local 312 du Pavillon New Chancellor Day Hall de la Faculté de droit de l'Université McGill (3644 rue Peel, Montréal). The panel will be in English and will be chaired by Paul Kennedy of CBC’s Ideas.
Kindly RSVP to firstname.lastname@example.org
Please do share this invitation with your network if you know people who might be interested in attending.
The CRISPR-Cas9 method of genome editing has given researchers unprecedented power and ease in altering the building blocks of life. The uses of this technology for combatting disease appear obvious, but the implications of establishing control over the genome are also potentially staggering. A panel of expert observers will engage in a conversation about the meaning of this technology for all of us.
- Prof. Alan Peterson of the Faculty of Medicine of McGill University is a distinguished researcher in oncology and is currently using CRISPR-Cas9 in his laboratory.
- Prof. Richard Gold of the Faculty of Law of McGill University is the lead author of the OECD Guidelines on Licensing Genetic Inventions.
- Prof. Margaret Somerville of the Faculty of Law of McGill University is a world-renowned thinker on medical ethics.
- Prof. Daniel Weinstock of the Faculty of Law of McGill University is the Director of the McGill Institute for Health and Social Policy.
- Mr. André Picard of the Globe and Mail is an acclaimed health reporter and columnist.
The panel will be chaired by Paul Kennedy of CBC’s Ideas.
A request for accreditation has been submitted to the Barreau du Québec for 1.5 hours of continuing legal education.